LeSCoD: a new clinical scale for the detection of Lewy body disease in neurocognitive disorders
LeSCoD for Lewy body Screening scale in Cognitive Disorders. 128 patients with Lewy bodies, Alzheimer's disease, and dementia were prospectively enrolled. The scale showed robust internal and external validity. It correlated with striatal dopamine uptake in 18F-DOPA PET. LeSCoD scale is a simple and reliable tool for the evaluation of Lewy body disease in routine clinical practice, with higher sensitivity and specificity than the existing criteria.

Related Post